|
WO2020047157A1
|
|
Citrate-free platelet additive solutions, compositions and methods thereof
|
|
AU2010250104A1
|
|
Inhibition of prion protein propagation by receptor associated protein (RAP). its derivatives, mimetics and synthetic peptides
|
|
AU2008200019A1
|
|
Methods for treating conditions associated with the accumulation of excess extracellular matrix
|
|
WO2007149431A2
|
|
Methods for reducing the range in concentrations of analyte species in a sample
|
|
WO2007149407A2
|
|
Identification and characterization of analytes from whole blood
|
|
WO2007149281A2
|
|
Combinatorial library for proteomic investigations
|
|
WO2007149280A2
|
|
Recovery of analytes using combinatorial libraries
|
|
US2007225226A1
|
|
C-reactive protein apheresis
|
|
US2006257844A1
|
|
Disinfection of biological fluids using asymmetric cyanine dyes
|
|
AU2005277190A1
|
|
Sequential protein isolation and purification schemes by affinity chromatography
|
|
WO2005003719A2
|
|
Decontamination of biological fluids using diphenylpyrilium compounds
|
|
WO2004091523A2
|
|
Method for identifying ligands specific for structural isoforms of proteins
|
|
WO2004090102A2
|
|
Prion protein binding materials and methods of use
|
|
EP1777297A1
|
|
Fluorescent substrates for detecting organophosphatase enzyme activity
|
|
US2006183103A1
|
|
Method for enriching adherent monocyte populations
|
|
AU2003270401A1
|
|
Hemostatic dressing
|
|
WO2004007757A1
|
|
Method for identifying individual active entities from complex mixtures
|
|
WO03089922A1
|
|
Method for detecting ligands and targets in a mixture
|
|
USRE38431E
|
|
Methods of production and use of liquid formulations of plasma proteins
|
|
AU2002365066A1
|
|
Mutant proteinase inhibitors and uses thereof
|
